Application Note

Blazar™ Platform: Rodent Virus Panel From The BioReliance® Portfolio

Scientist laboratory blood and genetic samples iStock-1140779754

We have a long history of developing innovative molecular technologies for cell line characterization and lot release testing for the biopharmaceutical industry. Our innovation continues with the Blazar™ Platform From The BioReliance® Portfolio, a novel degenerate PCR assay for the detection of a broad range of adventitious agents. Powered by the advantages of sensitivity, accuracy, and faster results and combined with the ability to detect a very broad range of viruses, this platform is well suited to cell line characterization and bulk-harvest lot release testing.

We are committed to accelerate testing and help the industry reduce the use of animal models. We have developed a rodent virus panel for the Blazar™ Platform From The BioReliance® Portfolio. This rodent virus panel provides a suitable alternative to the current in vivo MAP/HAP/RAP test that eliminates the need for animals.

Download our tech note Blazar™ Platform: Rodent Virus Panel From The BioReliance® Portfolio to learn more about our novel degenerate PCR assay designed for the detection of a broad range of adventitious agents.

VIEW THE APPLICATION NOTE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: